Innovative therapies: intraoperative intracavitary chemotherapy (Q35960207)

11 August 2017

1 reference

title

Innovative therapies: intraoperative intracavitary chemotherapy (English)

1 reference

11 August 2017

1 reference

2

David J Sugarbaker

1 reference

11 August 2017

Michael Y Chang

1

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

published in

Thoracic surgery clinics

1 reference

11 August 2017

volume

14

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

549-556

1 reference

Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Soft tissue sarcomas of the extremity. Multidisciplinary therapy employing hyperthermic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Eleven years' experience with hyperthermic perfusion for melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Hyperthermic perfusion for melanoma of the extremities: experience with 165 patients, 1967 to 1979

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

1 reference

7 January 2021

Correlation of the thermosensitivity of cells to their malignant potential.

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Combination intracavitary chemotherapy for malignant pleural disease

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intraperitoneal cisplatin with systemic thiosulfate protection

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Aggressive multimodality therapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

The importance of surgical staging in the treatment of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion

1 reference

https://api.crossref.org/works/10.1016%2FS1547-4127%2804%2900109-4

7 January 2021

10.1016/S1547-4127(04)00109-4

Identifiers

DOI

0 references

1 reference